Dennis Kim
1 clinical trials · Sponsor
| Record | Firm | Date |
|---|---|---|
| Belumosudil With Ruxolitnib as Second Line Therapy for Chronic Graft Versus Host Disease (cGvHD) After Steroid Failure (NCT07643025) | Dennis Kim | 2026-07-01 |
Track Dennis Kim automatically
Every clearance here is in the API, with alerts when new ones post.